# Evaluation of Safety and Effectiveness of TLD Radiofrequency Ablation in the Treatment of COPD

> **NCT05799664** · NA · RECRUITING · sponsor: **Hangzhou Broncus Medical Co., Ltd.** · enrollment: 200 (estimated)

## Conditions studied

- COPD

## Interventions

- **DEVICE:** TLD
- **OTHER:** Sham TLD procedure
- **OTHER:** Standard of care

## Key facts

- **NCT ID:** NCT05799664
- **Lead sponsor:** Hangzhou Broncus Medical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-04
- **Primary completion:** 2026-02
- **Final completion:** 2026-08
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05799664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05799664, "Evaluation of Safety and Effectiveness of TLD Radiofrequency Ablation in the Treatment of COPD". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05799664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*